A new HLA class I allele has been linked to a significantly increased risk for allopurinol-induced severe cutaneous adverse reactions.
TREOS Bio today announced the publication in Journal of Clinical Oncology - Oncology Advances of results from OBERTO-201 (NCT05130060), a Phase 1b study evaluating PolyPEPI1018, an off-the-shelf multi ...
The ExacTcell™ platform utilizes advanced immunological screening as well as laboratory testing to identify key targets recognized by the immune system across different HLA types. With this expanded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback